191 related articles for article (PubMed ID: 29903055)
1. iRGD-Mediated and Enzyme-Induced Precise Targeting and Retention of Gold Nanoparticles for the Enhanced Imaging and Treatment of Breast Cancer.
Yang Y; Chen Q; Li S; Ma W; Yao G; Ren F; Cai Z; Zhao P; Liao G; Xiong J; Yu Z
J Biomed Nanotechnol; 2018 Aug; 14(8):1396-1408. PubMed ID: 29903055
[TBL] [Abstract][Full Text] [Related]
2. A Novel Strategy through Combining iRGD Peptide with Tumor-Microenvironment-Responsive and Multistage Nanoparticles for Deep Tumor Penetration.
Cun X; Chen J; Ruan S; Zhang L; Wan J; He Q; Gao H
ACS Appl Mater Interfaces; 2015 Dec; 7(49):27458-66. PubMed ID: 26633260
[TBL] [Abstract][Full Text] [Related]
3. Coadministration of iRGD with Multistage Responsive Nanoparticles Enhanced Tumor Targeting and Penetration Abilities for Breast Cancer Therapy.
Hu C; Yang X; Liu R; Ruan S; Zhou Y; Xiao W; Yu W; Yang C; Gao H
ACS Appl Mater Interfaces; 2018 Jul; 10(26):22571-22579. PubMed ID: 29878758
[TBL] [Abstract][Full Text] [Related]
4. Normalizing Tumor Vessels To Increase the Enzyme-Induced Retention and Targeting of Gold Nanoparticle for Breast Cancer Imaging and Treatment.
Xiao W; Ruan S; Yu W; Wang R; Hu C; Liu R; Gao H
Mol Pharm; 2017 Oct; 14(10):3489-3498. PubMed ID: 28845990
[TBL] [Abstract][Full Text] [Related]
5. iRGD-decorated red shift emissive carbon nanodots for tumor targeting fluorescence imaging.
Yang Y; Wang X; Liao G; Liu X; Chen Q; Li H; Lu L; Zhao P; Yu Z
J Colloid Interface Sci; 2018 Jan; 509():515-521. PubMed ID: 28923749
[TBL] [Abstract][Full Text] [Related]
6. iRGD-modified lipid-polymer hybrid nanoparticles loaded with isoliquiritigenin to enhance anti-breast cancer effect and tumor-targeting ability.
Gao F; Zhang J; Fu C; Xie X; Peng F; You J; Tang H; Wang Z; Li P; Chen J
Int J Nanomedicine; 2017; 12():4147-4162. PubMed ID: 28615942
[TBL] [Abstract][Full Text] [Related]
7. An iRGD peptide fused superantigen mutant induced tumor-targeting and T lymphocyte infiltrating in cancer immunotherapy.
Song Y; Xu M; Li Y; Li Y; Gu W; Halimu G; Fu X; Zhang H; Zhang C
Int J Pharm; 2020 Aug; 586():119498. PubMed ID: 32505575
[TBL] [Abstract][Full Text] [Related]
8. Increased Gold Nanoparticle Retention in Brain Tumors by in Situ Enzyme-Induced Aggregation.
Ruan S; Hu C; Tang X; Cun X; Xiao W; Shi K; He Q; Gao H
ACS Nano; 2016 Nov; 10(11):10086-10098. PubMed ID: 27934068
[TBL] [Abstract][Full Text] [Related]
9. Matrix metalloproteinase-sensitive size-shrinkable nanoparticles for deep tumor penetration and pH triggered doxorubicin release.
Ruan S; Cao X; Cun X; Hu G; Zhou Y; Zhang Y; Lu L; He Q; Gao H
Biomaterials; 2015 Aug; 60():100-10. PubMed ID: 25988725
[TBL] [Abstract][Full Text] [Related]
10. Ligand-Mediated and Enzyme-Directed Precise Targeting and Retention for the Enhanced Treatment of Glioblastoma.
Ruan S; Xiao W; Hu C; Zhang H; Rao J; Wang S; Wang X; He Q; Gao H
ACS Appl Mater Interfaces; 2017 Jun; 9(24):20348-20360. PubMed ID: 28557433
[TBL] [Abstract][Full Text] [Related]
11. A dual strategy to improve the penetration and treatment of breast cancer by combining shrinking nanoparticles with collagen depletion by losartan.
Cun X; Ruan S; Chen J; Zhang L; Li J; He Q; Gao H
Acta Biomater; 2016 Feb; 31():186-196. PubMed ID: 26675124
[TBL] [Abstract][Full Text] [Related]
12. Activatable iRGD-based peptide monolith: Targeting, internalization, and fluorescence activation for precise tumor imaging.
Cho HJ; Lee SJ; Park SJ; Paik CH; Lee SM; Kim S; Lee YS
J Control Release; 2016 Sep; 237():177-184. PubMed ID: 27349354
[TBL] [Abstract][Full Text] [Related]
13. GSH-responsive SN38 dimer-loaded shape-transformable nanoparticles with iRGD for enhancing chemo-photodynamic therapy.
Lin C; Tong F; Liu R; Xie R; Lei T; Chen Y; Yang Z; Gao H; Yu X
Acta Pharm Sin B; 2020 Dec; 10(12):2348-2361. PubMed ID: 33354506
[TBL] [Abstract][Full Text] [Related]
14. The influence of the penetrating peptide iRGD on the effect of paclitaxel-loaded MT1-AF7p-conjugated nanoparticles on glioma cells.
Gu G; Gao X; Hu Q; Kang T; Liu Z; Jiang M; Miao D; Song Q; Yao L; Tu Y; Pang Z; Chen H; Jiang X; Chen J
Biomaterials; 2013 Jul; 34(21):5138-48. PubMed ID: 23582684
[TBL] [Abstract][Full Text] [Related]
15. Design of an Amphiphilic iRGD Peptide and Self-Assembling Nanovesicles for Improving Tumor Accumulation and Penetration and the Photodynamic Efficacy of the Photosensitizer.
Jiang Y; Pang X; Liu R; Xiao Q; Wang P; Leung AW; Luan Y; Xu C
ACS Appl Mater Interfaces; 2018 Sep; 10(37):31674-31685. PubMed ID: 30133254
[TBL] [Abstract][Full Text] [Related]
16. Furin-instructed aggregated gold nanoparticles for re-educating tumor associated macrophages and overcoming breast cancer chemoresistance.
Xie R; Ruan S; Liu J; Qin L; Yang C; Tong F; Lei T; Shevtsov M; Gao H; Qin Y
Biomaterials; 2021 Aug; 275():120891. PubMed ID: 34051669
[TBL] [Abstract][Full Text] [Related]
17. iRGD conjugated TPGS mediates codelivery of paclitaxel and survivin shRNA for the reversal of lung cancer resistance.
Shen J; Meng Q; Sui H; Yin Q; Zhang Z; Yu H; Li Y
Mol Pharm; 2014 Aug; 11(8):2579-91. PubMed ID: 24236909
[TBL] [Abstract][Full Text] [Related]
18. iRGD-mediated core-shell nanoparticles loading carmustine and O
Liu C; Yao S; Li X; Wang F; Jiang Y
J Drug Target; 2017 Mar; 25(3):235-246. PubMed ID: 27646474
[TBL] [Abstract][Full Text] [Related]
19. iRGD-coupled responsive fluorescent nanogel for targeted drug delivery.
Su S; Wang H; Liu X; Wu Y; Nie G
Biomaterials; 2013 Apr; 34(13):3523-33. PubMed ID: 23410678
[TBL] [Abstract][Full Text] [Related]
20. Tumor penetrability and anti-angiogenesis using iRGD-mediated delivery of doxorubicin-polymer conjugates.
Wang K; Zhang X; Liu Y; Liu C; Jiang B; Jiang Y
Biomaterials; 2014 Oct; 35(30):8735-47. PubMed ID: 25023394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
